ReviewCellular and molecular life sciences : CMLS2022

Modifier pathways in polyglutamine (PolyQ) diseases: from genetic screens to drug targets.

Marta Daniela Costa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.